Clinical Trials Directory

Trials / Terminated

TerminatedNCT05100901

Tolerance and Safety of an Oral Nutritional Supplement

Tolerance and Safety of an Oral Nutritional Supplement Containing Monoacylglycerol Oil (MAG Oil) as the Main Lipid Source in Healthy Adolescents and Adults

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
12 (actual)
Sponsor
Société des Produits Nestlé (SPN) · Industry
Sex
All
Age
12 Years
Healthy volunteers
Accepted

Summary

This is an open label, non-randomized, interventional, single arm study.

Detailed description

Primary objective is to assess whether the MAG oil (monoacylglycerol oil) containing study formula is well tolerated and safe when used as an ONS in healthy adults and adolescents. Secondary objectives: 1. Describe the incidence and characteristics of possible gastrointestinal intolerance symptoms 2. Describe changes in stool characteristics, specifically stool frequency and consistency 3. Describe changes in anthropometric parameters, particularly weight and body mass index (BMI) 4. Describe changes in blood parameters of lipid metabolism 5. Describe changes in hematological and serum biochemistry parameters 6. Describe daily ONS intake and assess dietary adherence to the study protocol

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTMAG oil oral nutritional supplement (ONS)The study product is suitable for use as an oral nutritional supplement (ONS).The study product contains MAG oil, hydrolyzed whey protein, simple carbohydrates, vitamins and minerals.

Timeline

Start date
2021-09-24
Primary completion
2021-10-15
Completion
2021-10-15
First posted
2021-10-29
Last updated
2023-04-05

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT05100901. Inclusion in this directory is not an endorsement.